Fagron purchased 46,000 of its own shares in the period from 27 October 2025 to 31 October 2025, totaling €946,821.80. These purchases are part of a share buy-back program to fulfill obligations under a long-term incentive scheme. To date, 111,000 shares have been purchased. More details are available on the share buy-back webpage. Fagron is a global leader in pharmaceutical compounding, providing personalized medicine in over 35 countries. Forward-looking statements in the press release are subject to risks and uncertainties. For more information, visit the provided link.

Read more at GlobeNewswire: Fagron’s share buy-back program: Weekly update